147 related articles for article (PubMed ID: 34139027)
1. Disparities in magnetic resonance imaging of the prostate for traditionally underserved patients with prostate cancer.
Quinn TP; Sanda MG; Howard DH; Patil D; Filson CP
Cancer; 2021 Aug; 127(16):2974-2979. PubMed ID: 34139027
[TBL] [Abstract][Full Text] [Related]
2. Evolving Use of Prebiopsy Prostate Magnetic Resonance Imaging in the Medicare Population.
Rosenkrantz AB; Hemingway J; Hughes DR; Duszak R; Allen B; Weinreb JC
J Urol; 2018 Jul; 200(1):89-94. PubMed ID: 29410202
[TBL] [Abstract][Full Text] [Related]
3. Cancer-specific outcomes for prostate cancer patients who had prebiopsy prostate MRI.
Li J; Patil D; Sanda MG; Filson CP
Urol Oncol; 2022 Feb; 40(2):58.e9-58.e15. PubMed ID: 34353711
[TBL] [Abstract][Full Text] [Related]
4. Racial and Ethnic Disparities in the Use of Prostate Magnetic Resonance Imaging Following an Elevated Prostate-Specific Antigen Test.
Abashidze N; Stecher C; Rosenkrantz AB; Duszak R; Hughes DR
JAMA Netw Open; 2021 Nov; 4(11):e2132388. PubMed ID: 34748010
[TBL] [Abstract][Full Text] [Related]
5. Adoption of Prebiopsy Magnetic Resonance Imaging for Men Undergoing Prostate Biopsy in the United States.
Liu W; Patil D; Howard DH; Moore RH; Wang H; Sanda MG; Filson CP
Urology; 2018 Jul; 117():57-63. PubMed ID: 29679601
[TBL] [Abstract][Full Text] [Related]
6. Impact of prebiopsy magnetic resonance imaging on biopsy and radical prostatectomy grade concordance.
Shoag JE; Cai PY; Gross MD; Gaffney C; Li D; Mao J; Nowels M; Scherr DS; Sedrakyan A; Hu JC
Cancer; 2020 Jul; 126(13):2986-2990. PubMed ID: 32320063
[TBL] [Abstract][Full Text] [Related]
7. Racial and Ethnic Variation in Receipt and Intensity of Active Surveillance for Older Patients With Localized Prostate Cancer.
Basourakos SP; An A; Davuluri M; Pinheiro LC; Al Awamlh BAH; Borregales LD; Luan D; Tamimi RM; Hu JC; Kensler KH
Urol Pract; 2024 May; 11(3):538-546. PubMed ID: 38640417
[TBL] [Abstract][Full Text] [Related]
8. Utilization trend of prebiopsy multiparametric magnetic resonance imaging and its impact on prostate cancer detection: Real-world insights from a high-volume center in southwest China.
Zhang C; Tu X; Dai J; Zhang Z; Shen C; Wu Q; Liu Z; Lin T; Qiu S; Yang L; Yang L; Zhang M; Cai D; Bao Y; Zeng H; Wei Q
Prostate; 2024 May; 84(6):539-548. PubMed ID: 38173301
[TBL] [Abstract][Full Text] [Related]
9. Impact of prebiopsy magnetic resonance imaging of the prostate on cancer detection and treatment patterns.
Liu W; Patil D; Howard DH; Moore RH; Wang H; Sanda MG; Filson CP
Urol Oncol; 2019 Mar; 37(3):181.e15-181.e21. PubMed ID: 30514604
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Prostate Biopsy with or without Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: An Observational Cohort Study.
Bryant RJ; Hobbs CP; Eyre KS; Davies LC; Sullivan ME; Shields W; Sooriakumaran P; Verrill CL; Gleeson FV; MacPherson RE; Hamdy FC; Brewster SF
J Urol; 2019 Mar; 201(3):510-519. PubMed ID: 30266332
[TBL] [Abstract][Full Text] [Related]
11. Impact of biparametric prebiopsy prostate magnetic resonance imaging on the diagnostics of clinically significant prostate cancer in biopsy naïve men.
Knaapila J; Autio V; Jambor I; Ettala O; Verho J; Kiviniemi A; Taimen P; Perez IM; Aronen HJ; Syvänen KT; Boström PJ
Scand J Urol; 2020 Feb; 54(1):7-13. PubMed ID: 31914846
[No Abstract] [Full Text] [Related]
12. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
[TBL] [Abstract][Full Text] [Related]
13. Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer.
Leapman MS; Dinan M; Pasha S; Long J; Washington SL; Ma X; Gross CP
JAMA Oncol; 2022 May; 8(5):687-696. PubMed ID: 35238879
[TBL] [Abstract][Full Text] [Related]
14. Association of Rurality, Race and Ethnicity, and Socioeconomic Status With the Surgical Management of Colon Cancer and Postoperative Outcomes Among Medicare Beneficiaries.
Ramkumar N; Colla CH; Wang Q; O'Malley AJ; Wong SL; Brooks GA
JAMA Netw Open; 2022 Aug; 5(8):e2229247. PubMed ID: 36040737
[TBL] [Abstract][Full Text] [Related]
15. Real-world use of MRI for risk stratification prior to prostate biopsy.
Siddiqui MR; Ansbro B; Shah PV; Aguiar JA; Li EV; Rich JM; Mahenthiran AK; Moataz SAS; Keeter MK; Mai Q; Mi X; Schaeffer EM; Ross AE
Prostate Cancer Prostatic Dis; 2023 Jun; 26(2):353-359. PubMed ID: 35551235
[TBL] [Abstract][Full Text] [Related]
16. Increasing Utilization of MRI Before Prostate Biopsy in Black and Non-Black Men: An Analysis of the SEER-Medicare Cohort.
Gaffney CD; Cai P; Li D; Margolis D; Sedrakyan A; Hu JC; Shoag J
AJR Am J Roentgenol; 2021 Aug; 217(2):389-394. PubMed ID: 34161136
[No Abstract] [Full Text] [Related]
17. Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial.
Tonttila PP; Lantto J; Pääkkö E; Piippo U; Kauppila S; Lammentausta E; Ohtonen P; Vaarala MH
Eur Urol; 2016 Mar; 69(3):419-25. PubMed ID: 26033153
[TBL] [Abstract][Full Text] [Related]
18. Prebiopsy multiparametric MRI-based risk score for predicting prostate cancer in biopsy-naive men with prostate-specific antigen between 4-10 ng/mL.
Dwivedi DK; Kumar R; Dwivedi AK; Bora GS; Thulkar S; Sharma S; Gupta SD; Jagannathan NR
J Magn Reson Imaging; 2018 May; 47(5):1227-1236. PubMed ID: 28872226
[TBL] [Abstract][Full Text] [Related]
19. Association between prediagnostic prostate-specific antigen and prostate cancer probability in Black and non-Hispanic White men.
Lee KM; Bryant AK; Lynch JA; Robison B; Alba PR; Agiri FY; Pridgen KM; DuVall SL; Yamoah K; Garraway IP; Rose BS
Cancer; 2024 Jan; 130(2):224-231. PubMed ID: 37927109
[TBL] [Abstract][Full Text] [Related]
20. Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer.
Ma TM; Agarwal N; Mahal B; Barragan-Carrillo R; Spratt D; Rettig MB; Valle LF; Steinberg ML; Garraway I; Vapiwala N; Xiang M; Kishan AU
JAMA Netw Open; 2023 Dec; 6(12):e2345906. PubMed ID: 38039002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
